Future of TAS-102 and regorafenib for patients with colorectal cancer.

Future of TAS-102 and regorafenib for patients with colorectal cancer.

647 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
Report 0 0
Category:
Description:
Howard S Hochster, MD of Yale Medical Center discusses the future of TAS-102 and regorafenib for patients with colorectal cancer at ASCO GI 2016
Up Next Autoplay